Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...

US drug makers are racing to plug looming 'patent cliff' revenue gaps - and increasingly they are turning to China biotechs ...

Since its inception, Aktis Oncology has raised roughly $346 million, including a $175 million Series B funding round in 2024, from life sciences institutional investors such as MPM BioImpact, Vida ...

To support tenants using AI, life sciences buildings need increased slab loads, electricity and water, all expensive upgrades for owners.

The final report, presented to New York Governor Kathy Hochul, outlines a path to translate investments in the state's biotech ecosystem into real-world outcomes. -- Executives from The Michael J. Fox ...

James B. Hunt Jr., a populist four-term governor who championed biotechnology as a new economic engine for North Carolina and ...

Equine-focused technology company EquiSeq was just issued a second patent for tech used to identify dangerous genetic ...

Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

Venture capital firm Aditum Bio is going all-out for a new collaboration with Fosun Pharma, launching a subsidiary with the ...

BioMarin said it is acquiring Amicus Therapeutics, maker of rare-disease drugs, for $4.8 billion. A new FDA program meant to ...

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...